We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:6054S
GW Pharmaceuticals PLC
17 April 2008
GW PHARMACEUTICALS PLC ("the Company")
Application has been made to the London Stock Exchange for admission to trading
on AIM in respect of a block listing of 300,000 ordinary shares of 0.1p each
("New Ordinary Shares").
The New Ordinary Shares will be issued from time to time pursuant to the
exercise of employee share options under the Company's Executive Share Option
Scheme 2001. On exercise the shares will be issued credited as fully paid and
will rank pari passu with the existing ordinary shares in issue.
It is expected that such admission will become effective on 23 April 2008.
For further information, please contact:
Adam George, GW Pharmaceuticals plc
Telephone: 01980 557000
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISBLGDSBUBGGIR
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
